Bank Of New York Mellon Corp Singular Genomics Systems, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $307,898 - $458,464	169,175 New	169,175 $340,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $41,590 - $78,688	16,636 Added 12.52%	149,558 $374,000
Q2 2022 Aug 15, 2022	SELL	$2.86 - $6.44 $25,731 - $57,940	-8,997 Reduced 6.34%	132,922 $507,000
Q1 2022 May 11, 2022	BUY	$5.94 - $12.09 $515,532 - $1.05 Million	86,790 Added 157.43%	141,919 $895,000
Q4 2021 Feb 11, 2022	BUY	$10.45 - $16.9 $41,601 - $67,278	3,981 Added 7.78%	55,129 $638,000
Q3 2021 Nov 12, 2021	BUY	$10.9 - $27.63 $239,919 - $608,163	22,011 Added 75.54%	51,148 $572,000
Q2 2021 Aug 11, 2021	BUY	$23.16 - $31.17 $674,812 - $908,200	29,137 New	29,137 $800,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.42B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.